
0:00
20:43
Flares, surgery and the postpartum period. Mette Julsgaard and Pradeep Mundre on whether active disease or a JAK inhibitor is the bigger risk, starting upadacitinib at 28 weeks, acute severe colitis and when to operate, vaccinating infants exposed to biologics.
More episodes from "UEG Podcast"



Don't miss an episode of “UEG Podcast” and subscribe to it in the GetPodcast app.








